BANK OF AMERICA CORP /DE/ - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 3 filers reported holding CASI PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$0
-100.0%
264
-99.8%
0.00%
Q4 2021$94,000
+40.3%
117,917
+111.1%
0.00%
Q3 2021$67,000
-38.5%
55,858
-20.4%
0.00%
Q2 2021$109,000
-22.7%
70,169
+19.4%
0.00%
Q1 2021$141,000
+104.3%
58,764
+151.5%
0.00%
Q4 2020$69,000
+228.6%
23,368
+68.1%
0.00%
Q3 2020$21,000
-54.3%
13,902
-24.8%
0.00%
Q2 2020$46,000
+142.1%
18,490
+103.7%
0.00%
Q1 2020$19,000
-62.7%
9,075
-45.2%
0.00%
Q4 2019$51,000
-32.9%
16,565
-27.2%
0.00%
Q3 2019$76,000
+38.2%
22,752
+31.7%
0.00%
Q2 2019$55,000
+103.7%
17,272
+93.0%
0.00%
Q1 2019$27,000
-76.9%
8,949
-69.1%
0.00%
Q4 2018$117,000
+101.7%
28,954
+132.9%
0.00%
Q3 2018$58,000
-7.9%
12,433
+63.8%
0.00%
Q2 2018$63,000
+125.0%
7,589
+13.4%
0.00%
Q1 2018$28,000
+833.3%
6,695
+569.5%
0.00%
Q4 2017$3,000
+50.0%
1,000
-12.6%
0.00%
Q3 2017$2,000
+100.0%
1,144
-2.3%
0.00%
Q2 2017$1,000
-50.0%
1,171
+2.4%
0.00%
Q1 2017$2,000
+100.0%
1,1440.0%0.00%
Q4 2016$1,000
-75.0%
1,144
-67.9%
0.00%
Q3 2016$4,000
+300.0%
3,562
+581.1%
0.00%
Q2 2016$1,000523
+182.7%
0.00%
Q1 2016$0185
-18.5%
0.00%
Q4 2015$02270.0%0.00%
Q3 2015$0
-100.0%
227
-28.4%
0.00%
Q2 2015$1,0003170.0%0.00%
Q1 2015$03170.0%0.00%
Q4 2014$0
-100.0%
317
-10.2%
0.00%
Q3 2014$1,0003530.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Wellington Shields Capital Management, LLC 2,188,547$1,751,0000.22%
Wellington Shields & Co., LLC 1,141,190$913,0000.18%
Ikarian Capital, LLC 1,223,067$978,0000.15%
Ground Swell Capital, LLC 18,638$15,0000.09%
Anson Funds Management LP 267,507$214,0000.02%
Sterneck Capital Management, LLC 40,000$32,0000.02%
FEDERATED HERMES, INC. 10,150,000$8,120,0000.02%
Roundview Capital LLC 122,453$98,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,677,146$1,342,0000.01%
RBF Capital, LLC 159,367$127,0000.01%
View complete list of CASI PHARMACEUTICALS INC shareholders